OpGen Inc
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, includ… Read more
Market Cap & Net Worth: OpGen Inc (OPGN)
OpGen Inc (PINK:OPGN) has a market capitalization of $40.60 Million ($40.60 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #27492 globally and #9206 in its home market, demonstrating a 24.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OpGen Inc's stock price $4.00 by its total outstanding shares 10149411 (10.15 Million).
OpGen Inc Market Cap History: 2015 to 2025
OpGen Inc's market capitalization history from 2015 to 2025. Data shows change from $1.93 Trillion to $40.60 Million (-68.81% CAGR).
OpGen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OpGen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.81x
OpGen Inc's market cap is 7.81 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
3.39x
OpGen Inc's market cap is 3.39 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.17 Trillion | $4.03 Million | -$19.17 Million | 289933.83x | N/A |
| 2017 | $189.59 Billion | $3.21 Million | -$15.39 Million | 59044.09x | N/A |
| 2018 | $52.78 Billion | $2.95 Million | -$13.37 Million | 17914.78x | N/A |
| 2019 | $2.29 Billion | $3.50 Million | -$12.45 Million | 655.55x | N/A |
| 2020 | $4.14 Billion | $4.21 Million | -$26.21 Million | 982.67x | N/A |
| 2021 | $2.03 Billion | $4.31 Million | -$34.81 Million | 471.41x | N/A |
| 2022 | $286.21 Million | $2.61 Million | -$37.28 Million | 109.79x | N/A |
| 2023 | $42.63 Million | $3.42 Million | -$32.67 Million | 12.47x | N/A |
| 2024 | $14.31 Million | $5.20 Million | $11.99 Million | 2.75x | 1.19x |
| 2025 | $40.60 Million | $5.20 Million | $11.99 Million | 7.81x | 3.39x |
Competitor Companies of OPGN by Market Capitalization
Companies near OpGen Inc in the global market cap rankings as of March 19, 2026.
Key companies related to OpGen Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
OpGen Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, OpGen Inc's market cap moved from $1.93 Trillion to $ 40.60 Million, with a yearly change of -68.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $40.60 Million | +183.69% |
| 2024 | $14.31 Million | -66.43% |
| 2023 | $42.63 Million | -85.11% |
| 2022 | $286.21 Million | -85.90% |
| 2021 | $2.03 Billion | -50.98% |
| 2020 | $4.14 Billion | +80.53% |
| 2019 | $2.29 Billion | -95.65% |
| 2018 | $52.78 Billion | -72.16% |
| 2017 | $189.59 Billion | -83.76% |
| 2016 | $1.17 Trillion | -39.47% |
| 2015 | $1.93 Trillion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OpGen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.60 Million USD |
| MoneyControl | $40.60 Million USD |
| MarketWatch | $40.60 Million USD |
| marketcap.company | $40.60 Million USD |
| Reuters | $40.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.